[HTML][HTML] A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria

OA Mokuolu, OA Bolarinwa, OR Opadiran, HA Ameen… - Malaria journal, 2023 - Springer
Background Recent reports of artemisinin partial resistance from Rwanda and Uganda are
worrisome and suggest a future policy change to adopt new anti-malarials. This is a case …

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria

O Mokuolu, O Bolarinwa, O Opadiran, H Ameen… - Malaria …, 2023 - europepmc.org
Background Recent reports of artemisinin partial resistance from Rwanda and Uganda are
worrisome and suggest a future policy change to adopt new anti-malarials. This is a case …

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria

OA Mokuolu, OA Bolarinwa… - Malaria …, 2023 - researchinformation.amsterdamumc …
Background: Recent reports of artemisinin partial resistance from Rwanda and Uganda are
worrisome and suggest a future policy change to adopt new anti-malarials. This is a case …

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria.

OA Mokuolu, OA Bolarinwa, OR Opadiran… - Malaria …, 2023 - search.ebscohost.com
Background: Recent reports of artemisinin partial resistance from Rwanda and Uganda are
worrisome and suggest a future policy change to adopt new anti-malarials. This is a case …

[PDF][PDF] A framework for stakeholder engagement in the adoption of new antimalarial treatments in Africa: a case study of Nigeria

OA Mokuolu, OA Bolarinwa, OR Opadiran, HA Ameen… - academia.edu
Recent reports of artemisinin partial resistance from Rwanda and Uganda are worrisome
and suggest a future policy change to adopt new antimalarials. We conducted a case study …

[PDF][PDF] A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria

OA Mokuolu, OA Bolarinwa, OR Opadiran, HA Ameen… - 2023 - researchgate.net
Background Recent reports of artemisinin partial resistance from Rwanda and Uganda are
worrisome and suggest a future policy change to adopt new anti-malarials. This is a case …

A framework for stakeholder engagement in the adoption of new antimalarial treatments in Africa: a case study of Nigeria

OA Mokuolu, OA Bolarinwa, OR Opadiran, HA Ameen… - 2022 - researchsquare.com
Methods This case study is based on an analysis of policy documents and stakeholders'
perspectives drawn from an empirical study conducted in Nigeria, 2019–2020. A mixed …

[HTML][HTML] A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria

OA Mokuolu, OA Bolarinwa… - Malaria …, 2023 - malariajournal.biomedcentral.com
Recent reports of artemisinin partial resistance from Rwanda and Uganda are worrisome
and suggest a future policy change to adopt new anti-malarials. This is a case study on the …

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria

OA Mokuolu, OA Bolarinwa, RO Oluwatumobi… - Malaria …, 2023 - search.proquest.com
Background Recent reports of artemisinin partial resistance from Rwanda and Uganda are
worrisome and suggest a future policy change to adopt new anti-malarials. This is a case …

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria.

OA Mokuolu, OA Bolarinwa, OR Opadiran, HA Ameen… - 2023 - cabidigitallibrary.org
Background: Recent reports of artemisinin partial resistance from Rwanda and Uganda are
worrisome and suggest a future policy change to adopt new anti-malarials. This is a case …